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Institute of Technology, Cambridge, MassachusettsABSTRACT Adhesion-based cell capture on surfaces in microfluidic devices forms the basis of numerous biomedical diagnos-
tics and in vitro assays. However, the performance of these platforms is partly limited by interfacial phenomena that occur at low
Reynolds numbers. In contrast, cell homing to porous vasculature is highly effective in vivo during inflammation, stem cell
trafficking, and cancer metastasis. Here, we show that a porous, fluid-permeable surface functionalized with cell-specific anti-
bodies promotes efficient and selective cell capture in vitro. This architecture is advantageous due to enhanced transport as
streamlines are diverted toward the surface. Moreover, specific cell-surface interactions are promoted due to reduced shear,
allowing gentle cell rolling and arrest. Together, these synergistic effects enable highly effective cell capture at flow rates
more than an order of magnitude larger than those provided by existing devices with solid surfaces.INTRODUCTIONThe identification, selection, and separation of a subpopula-
tion of target cells from a larger heterogeneous population is
essential for blood-based point-of-care diagnostics, person-
alized therapies, and cell biology (1–3). These cells of
interest may be rare and present in extraordinarily low num-
bers relative to the general population, necessitating the
processing of large sample volumes to accumulate a useful
number. For instance, 1 mL of whole blood contains billions
of red blood cells, millions of white blood cells, thousands
of hematopoietic stem cells, hundreds of endothelial pro-
genitor cells, and dozens of circulating tumor cells (4,5).
Thus, even a perfectly efficient separation scheme requires
at least 10 mL of whole blood to capture a usable sample
of the rarest cell types, which must be rapidly processed
to limit degradation and provide timely information to
patients.
A number of approaches have been demonstrated to sepa-
rate subpopulations of cells through their differential phys-
ical and biochemical phenotypes, which serve as handles for
direct manipulation. For example, physical fields can parti-
tion a complex mixture of cells based on size, shape,
deformability, density, electrical, magnetic, or optical pro-
perties (1,6). These approaches are advantageous because
they can be label-free and relatively high-throughput, but
are often confounded by the considerable variability found
even within a specific cell type. Instead, one can achieve
greater specificity using molecular recognition of unique
cell surface markers. Cells in solution can be labeled and
subsequently sorted with the use of fluorescent molecules
(7) or magnetic beads (8). Alternatively, cells can beSubmitted September 26, 2011, and accepted for publication December 9,
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0006-3495/12/02/0721/10 $2.00captured on solid surfaces functionalized with ligands
that are complementary to a specific cell surface receptor
(2,3). This approach has been used to isolate neutrophils
(9,10), monocytes (10), lymphocytes (10–12), fibroblasts
(13), endothelial progenitor cells (14), hematopoietic stem
cells (15), mesenchymal stem cells (16), and circulating
tumor cells (17–22). In these schemes, specific cell adhesion
depends on the interactions between the cell and surface,
and thus the operating conditions must be carefully
controlled.
Microfluidic platforms have been widely explored for
biomedical diagnostics because the samples can be pre-
cisely and reproducibly manipulated under well-defined
physicochemical conditions. At these small length scales,
the fluid dynamics are dominated by the high surface-to-
volume ratio and interfacial phenomena (23,24). Although
these effects have been cleverly exploited for various
applications, they severely hinder sample throughput for
analyte capture on solid surfaces (25,26). The first limita-
tion in this regime arises because the transport of analytes
to the surface may be too slow compared with the speed of
transport through the microfluidic device. This is particu-
larly problematic at high flow rates due to rapid advection
of analytes through the device (analogous to a high Peclet
number), as well as poor mixing of viscous flows (low
Reynolds number). These issues can be partially overcome
by increasing the effective surface area (17,20,21), as well
as by using herringbone chaotic micromixers to dis-
rupt fluidic streamlines through the microfluidic device
(18,19,27).
The second limitation subsequently arises if the reaction
of analytes with the surface does not have sufficient time
to occur. This is particularly problematic for cells moving
rapidly across the surface, because they require the forma-
tion of multiple adhesive bonds to be fully arrested (28).doi: 10.1016/j.bpj.2011.12.044
722 Mittal et al.Indeed, any bonds that do form between cellular receptors
and surface-immobilized ligands are more likely to disso-
ciate at high shear rates (29). On the other hand, a certain
threshold shear rate is necessary for adhesion-based capture
to occur selectively (2), because weaker nonspecific molec-
ular bonds are pulled apart more easily. This mechanism has
been used to select for certain subpopulations with differen-
tial expression levels using a precisely controlled shear rate
(11,12). Another danger is that cell sedimentation may
dominate at low flow rates, which would further decrease
selectivity. Overall, the effectiveness of adhesion-based
capture is limited at high flow rates both by transport of cells
to the surface and the subsequent reaction of the cells with
the surface.
Here, we show that microfluidic devices incorporating
porous, fluid-permeable surfaces functionalized with cell-
specific antibodies can be used to capture a rare subpopula-
tion of target cells with excellent efficiency, selectivity,
and throughput. The effectiveness of this platform arises
both from enhanced mass transport to the porous surface
(Fig. 1 A) and from enhanced cell-surface interactions that
promote dynamic rolling adhesion with high specificity
(Fig. 1 B). These cooperative mechanisms enable optimal
performance at extremely fast flow rates. These flow rates
are more than an order of magnitude faster than what can
be achieved with conventional devices.MATERIALS AND METHODS
Device fabrication and surface modification
The microfluidic devices consisted of a polycarbonate membrane (200 nm
pores, 10% porosity, 10 mm thick; GE Whatman, Piscatway, NJ) sand-
wiched between two polydimethylsiloxane layers (Fig. 1 C), as previously
described (30). Each layer contained an independent inlet and outlet
connected by a rectangular channel 100 mm or 250 mm high, 2 mm wide,
and 4 cm long. The membranes were covalently functionalized with
anti-EpCAM or anti-IgG (30 mg/mL) (R&D Systems, Minneapolis, MN)
according to a previously described process (31). Anti-EpCAM is selectiveC
D
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cells (5), whereas anti-IgG is noncomplementary to both cancer cells and
blood cells. See Supporting Material for additional details about the
fabrication.Sample preparation
Leukocytes (buffy coat) were isolated from whole blood via determin-
istic lateral displacement (32), fluorescently labeled (CellTrace Calcein
Green; Invitrogen, Carlsbad, CA), and resuspended to a concentration of
500,000/mL. PC3 human prostate cancer cells were labeled with a different
fluorescent dye (CellTracker Orange; Invitrogen) and spiked into the
sample at a ratio of 1:250 (2000/mL). See Supporting Material for addi-
tional details.Device operation
Samples were loaded into a 60 mL syringe, and a constant pressure syringe
pump was used to apply a constant flow through the top inlet while the
bottom inlet was closed. The top and bottom outlets were both open, and
the ratio of transverse membrane flux and axial channel flux was regulated
by means of the relative resistances of the outlet tubing (Supporting Mate-
rial). After the sample had been processed, the bottom outlet was closed and
phosphate-buffered saline was flowed through the top channel to remove
nonspecifically bound cells.
Cell capture was visualized with an upright epifluorescence microscope
(Nikon Eclipse 90i) using a 4X (Nikon Plan Fluor, NA ¼ 0.13) or 10X
objective (Nikon CFI Plan Apo, NA ¼ 0.45) at 10 frames per second
with a CCD camera (QImaging Retiga 2000R). At least 30 cells were
tracked per condition with the use of commercial software (Nikon
Elements AR3.1) and manually verified. We enumerated overall cell
capture in the device (Nc) and waste collection (Nout) using three different
emission spectra to identify cells (DAPI) and to distinguish spiked PC3
cells (TRITC) and background leukocytes (FITC). The capture efficiency
was calculated as the captured cells divided by the total cells flowed
through the device, i.e., Nc/(NcþNout) averaged over three experiments.
We performed a mass balance on the number of PC3 cells that
spiked into the cells by counting the cells that were injected into the
device, the cells that were captured on the porous membrane, and the
PC3 cells that exited the device into the collection well. There was
a ~4% difference between the intended number of cells injected into
the device and the number of cells that were accounted for by mass
balance.FIGURE 1 (A) Enhanced cell transport to a fluid-
permeable capture surface is achieved by diverting
streamlines. (B) Gentle cell rolling and arrest on
the capture surface occur due to reduced shear
and increased cell-surface interactions. (C) Scan-
ning electron micrograph of polycarbonate surface
with 200 nm pores and 10% porosity; schematic of
microfluidic device assembly and dimensions. (D)
Fluid flow rates through the top and bottom outlets
vary linearly with increasing pressure; their ratio is
constant and precisely controlled with the use of
high-resistance outlets. Each marker is the average
of five experiments per condition.
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Cell transport to surface is enhanced by diverting
streamlines
The effectiveness of conventional adhesion-based assays is
strongly diminished at high flow rates because most cells
do not reach the surface. To overcome this limitation, we
developed a two-chamber microfluidic device with a porous
capture surface sandwiched in between the chambers
(Fig. 1 C). These surfaces consisted of commercially avail-
able polycarbonate membranes with an overall porosity of
10% and average pore diameter of ~200 nm. Pores of this
size allow fluid permeation but are small enough to prevent
~10 mm cells from entering or becoming trapped (Fig. 1 C,
left). This device geometry allows a controlled fraction of
the incoming fluid flow to be diverted into the porous
membrane (Fig. 1 D, middle), whereas the remainder con-
tinues to the outlet (Fig. 1 D, top). These fluid flow condi-
tions were calibrated and found to be in good agreement
with the expected values based on the applied pressure
difference (Fig. 1 D, bottom). These devices were operated
with samples consisting of fluorescently labeled PC3 cancer
cells spiked at a ratio of 1:250 in a background population of
white blood cells.A
B
FIGURE 2 Theoretical particle trajectories (dashed black lines) and fluid veloc
fluid-permeable surface (A¼ 70%). The color bar corresponds to the magnitude o
in channels with (C) solid surface (A ¼ 0%) and (D) fluid-permeable surface (AThe limiting case of no fluid flux through the membrane is
essentially equivalent to flow past a solid surface, because
all of the fluid flux is exiting through the top outlet. The
cell trajectories in this scenario are well described by pres-
sure-driven Poiseuille flow in the axial direction, as well as
a constant sedimentation velocity due to the density differ-
ence of the cells (33). The nondimensionalized axial and
transverse fluid velocity field components Ux, Uy as a
function of (nondimensionalized) coordinate system (X ¼
x/h, Y ¼ y/h), are given by:
UxðX; YÞ ¼ 6

Y  Y2; UyðX;YÞ ¼ 0: (1)
The constant cell sedimentation perturbs the cell trajectories
slightly from the fluid streamlines due to the density differ-
ence Dr ¼ 0.03 g/cm3 (Supporting Material). A representa-
tive case is shown in Fig. 2 A for a cell sedimentation
velocity of 2 mm/s and an average flow velocity of <Ux> ¼
10,000 mm/s, corresponding to a flow rate Qin ¼ 6 mL/h and
cell radius Rc ¼ 5 mm. At these high flow rates, cells are
advected through the device so rapidly that they have very
little time to sediment. Based on the calculated cell trajecto-
ries for these conditions, only those cells that are initially
near the bottom of the channel (y < 10 mm) can reach theC
D
ity field vectors (color) in channels with (A) solid surface (A¼ 0%) and (B)
f fluid velocity vectors. Experimentally measured particle velocities tracked
¼ 70%).
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FIGURE 3 Experimental measurements of cell surface velocity
(markers) as a function of percentage permeation flux A and channel dis-
tance. Porous surface was not functionalized. Solid lines are best-fit linear
regressions. Each marker and error bar is the average and standard deviation
of 30 cells per condition.
724 Mittal et al.capture surface. Assuming that the cells are uniformly dis-
tributed at the 100 mm high entrance, this corresponds to
a case in which ~10% of the cells reach the surface, whereas
the remaining ~90% have no opportunity to interact with the
surface and get captured. These calculations are consistent
with experimental measurements of the cell trajectories
under these flow conditions obtained by fluorescencemicros-
copy, which show cells moving rapidly with constant axial
velocity throughout the 3000 mm field of view (Fig. 2 C).
As the fluid permeation flux through the membrane is
increased, more and more of the streamlines are diverted
from the top outlet to the porous membrane (Fig. 2 B). As
a result, cells traveling along the streamlines are now rapidly
advected directly to the capture surface, in contrast to the
slow and ineffective sedimentation in the previous scenario
(Fig. 2 A). For the fractional permeation flux through the
membrane A, the nondimensionalized velocity field compo-
nents are given by:
UxðX;YÞ ¼ 6ð1 AXÞ

Y  Y2;
UyðX;YÞ ¼ A

2Y3  3Y2: (2)
The calculated cell trajectories for this scenario (Supporting
Material) are illustrated for a representative case of 70%
permeation flux through the membrane, but with the same
flow rate as in the previous example (Qin ¼ 6 mL/h).
In this case, the calculated cell trajectories do not deviate
significantly from the streamlines (<1%) because ad-
vection (~10,000 mm/s) dominates over sedimentation
(~2 mm/s) and hydrodynamic effects. These calculations
are corroborated by experimental measurements of the
cell trajectories (Fig. 2 D), which show that the axial
velocity Ux rapidly decreases from an initial value of
2000 mm/s at x ¼ 2.4 cm to ~200 um/s at x ¼ 2.7 cm as
the cell is transported to the surface and the transverse
velocity Uy becomes more significant. Because of the
device geometry and the rapid axial velocity of the cell,
it is difficult to directly measure the height of the cell
during its trajectory. However, a qualitative comparison
of the calculated cell trajectories (Fig. 2 B) and the exper-
imentally measured cell axial velocities (Fig. 2 D) suggests
that these cells entered the device at a height roughly
halfway between the bottom and top. According to the
calculated streamlines, all cells that enter the channel
within 70 mm of the bottom surface (~70%) should be
captured, and the remaining 30% of cells should exit the
device at the top outlet. Experimentally, the total fraction
of cells that are transported to the porous capture surface
scales linearly with the percentage of the fluid flux into
the membrane (Fig. S3).
An important implication of the streamline calculation is
that when permeation occurs, the axial fluid velocity Ux
decreases linearly along the length of the device. As a result,
the shear rate near the surface is also expected to decrease
with increasing distance x, reaching a minimum at the endBiophysical Journal 102(4) 721–730of the porous surface. To verify this trend, we experimen-
tally measured the cell surface velocity uc(x) at three loca-
tions along the length of the device for various values
of A at a constant flow rate (Qin ¼ 6 mL/h) and fit the
data using linear regression (Fig. 3). We then compared
these measurements with the hydrodynamic model pro-
posed by Goldman et al. (34) for a particle moving near
a solid surface due to a shear field, using the following
scaling for cell surface velocity:
ucðxÞ  uc;0

1 Ax
L

; (3)
where uc,0 is the cell surface velocity at the entrance and L is
the channel length. The measured velocities and Goldman
model show good agreement for A ¼ 50% (Fig. S4).
However, at larger permeation fluxes, the experimental
cell surface velocities are consistently slower than the
expected values by several hundred microns per second.
This suggests that the cell surface velocity is not solely
dictated by the local shear field, but may have addi-
tional inhibitory interactions with a porous surface that
do not occur on a solid surface. These cell-surface in-
teractions are examined in more detail in the following
section.Cell-surface interactions are promoted by a fluid
permeable surface
The effectiveness of cell capture assays also depends on the
arrest of cell motion on the surface, which occurs through
the competition of specific biomolecular bond formation
and local shearing forces. Cells near a surface have been
Rolling Cell Capture on Porous Membranes 725observed to roll at constant velocity due to hydrodynamic
interactions, which is essential for selective capture both
in vitro and in vivo. We examined representative individual
cell trajectories near a porous surface functionalized with
noncomplementary IgG antibodies (Fig. 4 A). Up until
time t ¼ 1 s, the measured axial velocity Ux rapidly
decreases as the cell approaches the surface, after which it
maintains a reduced, constant velocity (Fig. 4 B). Because
the IgG antibodies cannot form strong, specific biomolec-
ular bonds with the cellular receptors, motion is never
completely arrested on the surface. However, the velocity
shows surprising fluctuations where the cell appears to
temporarily pause its motion on the surface (Fig. 4 A, inset).
The magnitude of this fluctuation (Duc ~ 350 mm/s) is
considerably larger than the standard deviation (SD) of the
velocity before and after this event (su ~ 40 mm/s). These
fluctuations may occur because of local differences in sur-
face porosity, which apply slightly stronger suction forces
to the cell to slow down its motion. This mechanism is
clearly insufficient to capture cells permanently, but it is
likely to influence the binding kinetics in a way that does
not occur on a solid surface.
These velocity fluctuations increase in frequency and
duration on porous surfaces that have been functionalized
with anti-EpCAM antibodies (su ~ 130 mm/s; Fig. 4 C),
which are complementary to cancer cells of epithelial originA
B
FIGURE 4 Instantaneous velocity and displacement trajectories for PC3 cance
ing motion at constant speed, and (C and D) anti-EpCAM fluid-permeable surfbut not leukocytes (5). In these representative trajectories,
cells again reach the porous surface around time t ¼ 1 s and
show a similar decrease in axial velocity, indicating they
are being advected to the surface. However, rather than
continuing at a constant diminished velocity (Fig. 4 B),
these cells continue to decelerate and are completely arrested
within a few seconds (Fig. 4D). The permeation flux through
a porous surface thus appears to promote the kinetics of
strong, specific biomolecular bond formation by slowing
down cell rolling across the surface. As evidenced by the
previous example with noncomplementary anti-IgG, this
mechanism is not strong enough to irreversibly stabilize
cell motion against the local shear field. However, in the
presence of complementary anti-EpCAM, this enhanced
cell-surface interaction allows specific cell capture to con-
tinue to occur even at fast total flow rates. Essentially, these
conditions of highly reduced shear and an additional braking
suction mechanism near a permeable surface lead to con-
ditions comparable to those found on a solid surface at
dramatically lower flow rates and shear.Cell capture on fluid-permeable surfaces exceeds
solid surfaces at elevated flow rates
The capture efficiency of PC3s on both porous and
solid surfaces functionalized with either noncomplementaryC
D
r cells transported to (A and B) noncomplementary anti-IgG, exhibiting roll-
aces at x ¼ 3 cm with A ¼ 70%, exhibiting rolling before complete arrest.
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726 Mittal et al.anti-IgG or complementary anti-EpCAM are plotted as a
function of total flow rate in Fig. 5 A. With a mixture of
PC3s and leukocytes at a ratio of 1:250, nonspecific capture
of PC3s is minimal (~10%) on a solid anti-IgG surface due
to the lack of complementary bonds and decreases rapidly
with increasing flow rates. For a porous anti-IgG surface
(A ¼ 70%), the cell capture rate is slightly higher (~20%)
and decreases more gradually with increasing flow rate,
reflecting nonspecific adsorption due to the enhanced trans-
port to the surface as well as suction effects. For the solid
anti-EpCAM surface, the capture efficiency achieves
a maximum value of ~60% only at low flow rates (Qin <
0.3 mL/h). The capture efficiency drops off rapidly withA
B
FIGURE 5 (A) Capture efficiency of PC3 cancer cells at increasing flow
anti-EpCAM solid surfaces (red triangles), noncomplementary anti-IgG poro
Each marker and error bar is the average and SD of three experiments. (B) Captu
surface at Qin¼ 6 mL/h and A ¼ 70%. The transverse wall velocity vw0 ¼ 141 mm
x ¼ 3 cm for (C) anti-EpCAM porous surface, (D) anti-IgG porous surface,
is 100 mm.
Biophysical Journal 102(4) 721–730increasing flow rate, becoming negligible by Qin ¼
1.5 mL/h. In comparison, the porous anti-EpCAM surface
(A ¼ 70%) achieves the optimal capture efficiency of
70 5 3% up to relatively high flow rates of Qin ¼ 6 mL/h
(Fig. 5 A). This is consistent with the theoretical maximum
of 70% based on the fraction of streamlines that are expected
to reach the surface. In comparison, at this flow rate, no cells
are captured on the flat surface for both anti-EpCAM and
anti-IgG, and only a few cells are nonspecifically adsorbed
on the anti-IgG porous surface (Fig. 5, C–F). As the flow
rate is further increased with the anti-EpCAM porous
surface, the cell capture efficiency decreases to 15% at
Qin ¼ 30 mL/h. Nevertheless, the maximum effective flowD
C
E
F
rates on complementary anti-EpCAM porous surfaces (red squares),
us surfaces (green circles), and anti-IgG solid surfaces (green triangles).
re profile varies along the channel length on an anti-EpCAM porous capture
/s. (C–F) Representative fluorescence micrograph of captured PC3 cells at
(E) anti-EpCAM solid surface, and (F) anti-IgG solid surface. Scale bar
Rolling Cell Capture on Porous Membranes 727rate of the porous anti-EpCAM surface is 20-fold higher
than that on the solid anti-EpCAM surface, enabling a
potentially transformative enhancement in processing
throughput.
The shear-dependent capture of cells is illustrated by
the concentration profile along the length of the channel
(Fig. 5 B). A stitched image of the entire length of the device
at representative flow conditions (A ¼ 70%, Qin ¼ 6 mL/h)
shows that cell capture increases cumulatively with dis-
tance, reaching ~70% at x ¼ 4 cm as the shear field linearly
decreases.Optimizing experimental conditions to maximize
capture efficiency and selectivity
One consideration unique to this device architecture is that
cells may be advected downward so rapidly that they over-
whelm the capture surface. This would suppress the effec-
tiveness of the device because layers of accumulated cells
would block access to the capture surface (‘‘caking’’) and
ultimately impede transverse fluid flow through the surface.
To avoid this scenario, the flux of cells that are being ad-
vected to the surface must not exceed the flux of cells that
are translating across the surface. One can achieve this
condition at a given bulk cell concentration by making the
permeation flux as large as possible while retaining suffi-
cient axial flow to drive cell rolling due to shear stress.
Romero and Davis (35) previously considered the scenario
of hard spheres accumulating at a porous surface, and
derived an expression for a critical distance xcr where parti-
cles become close-packed in a cake layer:
xcr ¼ R
4
ctðxÞbQcrð40Þ
40U
3
w0
; (4)
where a is the particle radius, t is the surface shear stress, 40
is the initial bulk volume fraction, and m0 is the solution
viscosity. The critical permeation flux bQcr is
A BbQcrð40Þ ¼
Z4max
40
8<
:
Z4max
40
Dð40Þd40
40h2ð40Þ
9=
; ð4 40ÞDð4Þd44hð4Þ ; (5)
where 4max is the maximum packing density on the surface,
assumed to be ~0.6 for hard spheres. This is a conservative
estimate that may underestimate the packing density of
deformable cells (35). Nevertheless, the empty space
between cells in a close-packed layer (~40%) is still consid-
erably larger than the membrane porosity (~10%), making it
unlikely that a single close-packed layer of cells would block
a significant number of pores. This calculation thus assumes
that the presence of ~10 mm cells does not affect the fluidic
resistance of the membrane or associated transverse flux.
Phase diagrams for the critical distance xcr as a function
of axial distance x and initial cell volume fraction 40 at
varying permeation fluxes are shown in Fig. 6 and Fig. S5.
To prevent caking, the critical distance xcr should exceed
the device length L at any point along the length of the
channel so that the particle fraction on the porous surface
never reaches its maximum cell packing density, 4max.
In general, the critical distance xcr decreases with increasing
initial cell volume fraction 40, because a smaller enhance-
ment in concentration is required to reach the maximum.
In the case of minimal permeation flux (A ¼ 10%), slow
advection to the surface means that caking will only occur
at relatively high bulk volume fractions. For instance,
for 40¼ 0.4 ~ 2 $ 106 cells/mL, 4max is reached at xcr¼ 3 cm
(Fig. 6 A). Experimentally, operating in this regime leads to
a visible buildup of white blood cells on the reaction
surface, despite the lack of specific cell-surface interactions.
A further increase to 40 ¼ 0.45 ~ 2.5 $ 106 cells/mL, corre-
sponds to xcr essentially at the entrance, which is not a usable
condition. In general, operating at this minimal flux regime
(A ¼ 10%) is both inefficient and unselective because 90%
of the cells never reach the surface, but those that do are not
subjected to sufficient shear to remove white blood cells
while retaining cancer cells.FIGURE 6 Phase diagram of the critical
distance (xcr) where the volume fraction of
cells reaches the maximum close packing
(4w ~ 4max ~ 0.6) as a function of the initial volume
fraction 4o and channel location. (A) Low perme-
ation flux (A ¼ 10%). (B) High permeation flux
(A ¼ 70%). At a critical value of initial volume
fraction, the maximum close packing is reached
along the length of the channel, causing excess
cell buildup (caking) and hindering cell capture
(white dotted line). Devices were operated in the
optimum regime (4o ¼ 0.1, Qin ¼ 6 mL/h, A ¼
70%) to maximize throughput without excess cell
buildup (red line).
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728 Mittal et al.At the higher permeation flux described previously
(A ¼ 70%) and 40 ¼ 0.4, xcr ¼ 0.8 cm, corresponding to
caking within the device (Fig. 6 B). Instead, at 40 ¼ 0.1,
corresponding to ~500,000 cells/mL, the critical length
xcr ¼ 5 cm is larger than the length of the channel (L ¼
4 cm) and caking should not occur within the device. Exper-
imentally, device operation was optimal under these condi-
tions, and efficient cell transport, selective capture, and
minimal accumulation of white blood cells were achieved
at relatively high flow rates.DISCUSSION
Conventional platforms based on adhesion-based cell
capture on solid surfaces exhibit highly diminished capture
efficiency at elevated flow rates due to two coupled mecha-
nisms. First, the rapid advection of cells through the device
limits the transport of cells to the capture surface. As a result,
only a small fraction of the total cells in a sample actually
reach the surface. Second, cells near the surface experience
strong shear stresses that cause rapid rolling and translation
across the surface. The limited interaction between cellular
receptors and surface ligands hinders the formation of
strong adhesive bonds, and any transient bonds that do
form are more likely to dissociate at elevated forces.
Although the first limitation can be addressed by increasing
the capture surface area or enhancing mixing, the second
limitation is more difficult to overcome, because the shear
stress scales directly with the flow rate near a solid surface.
Given this limiting flow rate, one can still increase the over-
all throughput by scaling up to multiple parallel channels,
but this approach soon becomes impractical for device
manufacture and readout.
In this work, we have demonstrated a fluid-permeable
capture surface that overcomes both of these limitations,
enabling excellent capture efficiency and selectivity at
flow rates 20-fold higher than those achieved by a compa-
rable device with a solid surface. Remarkably, by control-
ling the fluid permeation through the membrane, we were
able to divert streamlines into the membrane even at high
flow rates. On a cellular scale, the transverse flux has an
additional advantage in that the transverse flow through
the membrane significantly decreases the axial fluid flow
near the surface. Thus, despite high overall flow rates, cells
near the surface experience a considerably diminished shear
as well as a braking suction force. In contrast, these reduced
surface shear conditions can only be achieved near a solid
surface at substantially lower flow rates. One can indepen-
dently vary these transport and cell-surface mechanisms
by adjusting the overall flow rate or the ratio of transverse
to axial flux, respectively, thereby optimizing the device
operation.
Another phenomenon that occurs with fluid-permeable
surfaces is a linear decrease in the shear stress along the
length of the channel, which is reminiscent of microfluidicBiophysical Journal 102(4) 721–730devices that use a Hele-Shaw channel geometry (with solid
surfaces) (36). As a result, the density of captured cells
increases with distance in the channel, because cells are
more likely to remain arrested at lower shear. This trend is
the opposite of what is often observed on solid surfaces,
where the shear is constant and the density of captured cells
decreases exponentially along the length of the device (12).
In both cases, the spatial distribution of captured cells
reflects how the target subpopulation interacts specifically
with an antibody-functionalized surface at a particular shear
rate. An intriguing possibility is that additional biophysical
information, such as the variation in receptor expression
levels, may be encoded in this distribution. For instance,
circulating tumor cells in a clinical sample may exhibit
much greater heterogeneity than a spiked cell line (5),
leading to a different distribution of captured cells in the
channel. These effects could be explored with the use
of improved surface chemistries (37) as well as spatial
patterning schemes such as stripes (38), gradients (39), or
discrete regions of different capture antibodies (40).
In addition to selective cell capture, microfluidic plat-
forms incorporating porous surfaces may be useful as a
well-controlled in vitro assay to elucidate cell trafficking
behaviors in vivo. Indeed, a variety of cell types undergo
rolling and arrest in vivo to enable separation from a highly
heterogeneous background population (41). For example,
leukocytes are selectively recruited from the circulation to
home in on sites of inflammation (42), and mesenchymal
stem cells participate in organogenesis, wound-healing,
and natural cell turnover (43). Similar strategies may be
utilized by circulating tumor cells before extravasation
and metastatic colonization take place (44,45). Many of
these behaviors are associated with a porous vasculature,
such as capillaries in the bone marrow and discontinuous
fenestrated sinusoid cells in the liver (46). This vascular
permeability can be enhanced during acute and chronic
inflammation as well as in cancer (47). Although cell rolling
and adhesion are frequently observed along sinusoids in vivo
(48), previous in vitro assays have only used solid surfaces
to elucidate the biochemical interactions that occur between
cellular receptors and surface ligands.
Byusing porous surfaceswith slightly larger pores,wemay
be able to delve deeper into the multistep trafficking cascade
under biomimetic conditions. In particular, this geometry is
highly reminiscent of the transwell/Boyden chamber assay
for chemotaxis studies (49). After capturing cells, one could
reconfigure the flow conditions in the microfluidic device to
minimize transverse permeation while achieving identical
continuous flows in the top and bottom chambers. If the
bottomchamberwere loadedwith a chemoattractant solution,
a stable gradient would be formed through the membrane,
promoting cell migration through the pores. A further step
could be to culture a layer of endothelial cells on the porous
surface instead of simply patterning ligands (50–52). By
combining biomimetic features with precisely controlled
Rolling Cell Capture on Porous Membranes 729microfluidic flows, we may be able to recapitulate complex
biological behaviors in vitro, replicating the dynamics of
the leaky vasculature within tumor microenvironments.
Fluid-permeable surfaces represent a powerful and versa-
tile approach for specific analyte capture because they over-
come fundamental limitations associated with interfacial
effects near solid surfaces (53,54). This work elucidates
the physical mechanisms that govern both transport and
cell-surface interactions in these conditions, and thus
establishes engineering design rules for future devices. It
is expected that the overall throughput can be further
increased by scaling up the device architecture with addi-
tional demultiplexed channels. This might yield an addi-
tional order-of-magnitude increase in throughput, building
on the demonstrated 20-fold enhancement in effective
flow rate (relative to comparable devices). The ability to
process hundreds of milliliters of blood efficiently may
lead to transformative approaches for point-of-care diagnos-
tics and personalized medicine, such as the capture of
extremely rare antigen-specific T-cells or fetal cells.SUPPORTING MATERIAL
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